Starting as a one-man-show when he began the Greek affiliate in 2009, Orion Pharma’s General Manager, Thanassis Panopoulos discusses the company’s high level of resiliency, the challenges of bringing a Finnish company to Greece, communicating the value of their life-saving products to relevant stakeholders, as well as their objective to maintain a healthy business in the years ahead.
Mr. Panopoulos, you have been the Country Manager for Orion Pharma for the last seven years, thus being the one responsible for spearheading the company throughout the crisis. What has been your leadership style in getting through this period?
"There are two main products in our local portfolio. Primarily, our key product is Simdax, which is a unique product in that it is the only calcium sensitizer available in the market."
